GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2476 - 2500** of **4050** in total

« First

‹ Prev

…

96

97

98

99

100

101

102

103

104

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	3	mild	G32473MI	500
IgG	Patient 2	3	mild	G32473MI	11348
IgM	Patient 2	3	mild	G32473MI	292
IgA	Patient 3	-180	mild	G32473MI	266
IgA	Patient 3	11	mild	G32473MI	369
IgG	Patient 3	-180	mild	G32473MI	38
IgM	Patient 3	-180	mild	G32473MI	59
IgA	Patient 3	4	mild	G32473MI	416
IgG	Patient 3	11	mild	G32473MI	50
IgG	Patient 3	4	mild	G32473MI	51
IgM	Patient 3	11	mild	G32473MI	65
IgM	Patient 3	4	mild	G32473MI	74
IgA	Patient 4	12	mild	G32473MI	457
IgG	Patient 4	12	mild	G32473MI	94
IgM	Patient 4	12	mild	G32473MI	407
IgA	Patient 1	10	moderate	G31265MS	408
IgA	Patient 1	22	moderate	G31265MS	420
IgA	Patient 1	6	moderate	G31265MS	355
IgG	Patient 1	10	moderate	G31265MS	25
IgG	Patient 1	22	moderate	G31265MS	36
IgG	Patient 1	6	moderate	G31265MS	23
IgM	Patient 1	10	moderate	G31265MS	50
IgM	Patient 1	22	moderate	G31265MS	176
IgA	Patient 2	15	mild	G31265MS	396
IgA	Patient 2	24	mild	G31265MS	420